Jorge Alvarez Guzman

Jorge Alvarez Guzman has a diverse work experience in the field of medical science and clinical trials. Jorge started their career as a Clinical Pharmacist at Complejo Asistencial Univesitario de Salamanca (CAUSA) in 2017, where they were involved in tasks such as clinical trials and individualized drug formulation. In 2017, they also joined MSD as a Junior Medical Science Liaison & Medical Affairs, where they gained knowledge and experience in disease areas like lipids, atherosclerosis, heart failure, and rare disease pulmonary arterial hypertension (PAH).

In 2018, Jorge joined IQVIA as a Clinical Trial Liaison II, covering EMEA and LATAM regions and focusing on cardiology, pneumology, and PAH. Their responsibilities included supporting healthcare professionals, providing practical support to study sites, conducting recruitment training sessions, and building collaborative relationships. Jorge later took on the role of Senior Clinical Trial Liaison and then became a Team Lead ERG LGTBI+ IBERIA in 2020. In 2021, they became a Project Manager Clinical Trial Liaison at IQVIA, where they worked on clinical trial development in cardiology, pneumology, and PAH, specifically in phase 2, phase 2b/3, phase 3, and open-label extension trials. Jorge also gained expertise in PAH therapies such as prostacyclin and tyrosine kinase pathway.

Most recently, Jorge joined Aerovate Therapeutics, Inc. in 2022 as an Associate Director - Medical Science. Although specific details about this role are not provided, it can be assumed that they continue to utilize their experience and knowledge in medical science and clinical trials to contribute to the company's goals.

Overall, Jorge Alvarez Guzman has had a progressive career in the field of medical science, clinical trials, and medical affairs, gaining expertise in various disease areas and therapeutic areas.

Jorge Alvarez Guzman's education history includes the following:

- From 2012 to 2017, they attended Facultad de Farmacia, Universidad de Salamanca, where they obtained a Grado degree in Farmacia.

- In 2017, they enrolled at Talento-EPHOS and completed a Master of Science (MSc) degree in Clinical Research and Pharmaceutical Medicine in 2018.

In addition, Jorge has obtained several certifications:

- In October 2020, they obtained certifications in "Creating Positive Conversations with Challenging Customers," "Estrategias para tomar decisiones," "Giving and Receiving Feedback," and "Pensamiento estratégico" from LinkedIn.

- In July 2020, they obtained a certification in "Building Resilience" from LinkedIn.

- In April 2020, they obtained certifications in "Liderazgo y trabajo en equipo" and "Trabajo en equipo" from LinkedIn.

- In March 2020, they obtained a certification in "Being a Good Mentor" from LinkedIn.

- In December 2018, they obtained a certification in "Teletrabajo" from LinkedIn.

- In June 2017, they obtained a certification in "Análisis Práctico de APPS y recursos electrónicos al ámbito farmacéutico para uso en tecnología" from Universidad de Salamanca.

- In June 2017, they obtained a certification in "Taller AUSAF: Abordaje de la gripe y resfriado desde la farmacia comunitaria" from Universidad de Salamanca.

- In May 2017, they obtained a certification in "Curso teórico-práctico. Primeros auxilios para farmacéuticos" from Universidad de Salamanca.

- In June 2015, they obtained a certification in "Aptitud curso: Detección del fraude alimentario utilizando técnicas de análisis de ADN" from Universidad de Salamanca.